These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 82542)

  • 1. Surface membrane changes of T cells induced by syngeneic tumour cells. I. Formation and uptake of complexes of Ig and tumour antigens by T cells.
    Dular U; Chow DA; Paraskevas F
    Int J Cancer; 1978 Nov; 22(5):611-20. PubMed ID: 82542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface membrane changes of T cells induced by syngeneic tumour cells. II. T-cell defects induced by small tumour cell inocula or tumour cell antigens.
    Chow DA; Paraskevas F; Dular U
    Int J Cancer; 1978 Nov; 22(5):621-9. PubMed ID: 309866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of T cells carrying receptors for complexes of Ig and antigen.
    Paraskevas F; Lee ST; Orr KB
    Immunol Commun; 1976; 5(6):501-16. PubMed ID: 1086824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus-infected mice.
    Cerny J; Essex M; Thomas DB
    Int J Cancer; 1976 Aug; 18(2):197-204. PubMed ID: 60287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface antigen expression on chemically induced murine leukaemias.
    Birch JM; Moore M; Craig AW
    Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants.
    Basten A; Miller JF; Abraham R
    J Exp Med; 1975 Mar; 141(3):547-60. PubMed ID: 46915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells.
    Bartnes K; Hannestad K
    Immunology; 2000 Apr; 99(4):510-22. PubMed ID: 10792498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.
    Fulcher DA; Lyons AB; Korn SL; Cook MC; Koleda C; Parish C; Fazekas de St Groth B; Basten A
    J Exp Med; 1996 May; 183(5):2313-28. PubMed ID: 8642340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface components of carcinogen-induced lymphoid tumors in SJL/J mice.
    Haimovich J; Bergman Y; Linker-Israeli M; Haran-Ghera N
    Eur J Immunol; 1977 Apr; 7(4):226-30. PubMed ID: 405224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in mice.
    Dent LA; Spencer LK; Attridge S; Finlay-Jones JJ
    Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():403-12. PubMed ID: 2696727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules.
    Glimcher LH; Longo DL; Green I; Schwartz RH
    J Exp Med; 1981 Nov; 154(5):1652-70. PubMed ID: 6170721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection in vivo 6 hours after immunization of a mediator with possible antisuppressor activity.
    Maghazachi AA; Lee ST; Paraskevas F
    Eur J Immunol; 1983 Oct; 13(10):799-804. PubMed ID: 6227487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukaemia-associated antigens.
    Ting CC; Rogers MJ
    Nature; 1977 Apr; 266(5604):727-9. PubMed ID: 301609
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.